{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:33:51Z","timestamp":1793828031380,"version":"4.6.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T00:00:00Z","timestamp":1639180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T00:00:00Z","timestamp":1639180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91949121"],"award-info":[{"award-number":["91949121"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Applied Basic Research Foundation of Guangdong Province","award":["2021A1515011099"],"award-info":[{"award-number":["2021A1515011099"]}]},{"name":"Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University","award":["2017J010"],"award-info":[{"award-number":["2017J010"]}]},{"name":"Nanfang Hospital Talent Introduction Foundation of Southern Medical University","award":["123456"],"award-info":[{"award-number":["123456"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00259-021-05646-z","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T22:02:37Z","timestamp":1639173757000},"page":"2833-2843","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["[18F]FAPI-42 PET imaging in cancer patients: optimal acquisition time, biodistribution, and comparison with [68Ga]Ga-FAPI-04"],"prefix":"10.1007","volume":"49","author":[{"given":"Kongzhen","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjiang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6288-5578","authenticated-orcid":false,"given":"Ganghua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,11]]},"reference":[{"key":"5646_CR1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S1357-2725(03)00262-0","volume":"36","author":"P Bu\u0161ek","year":"2004","unstructured":"Bu\u0161ek P, Mal R, \u0160edo A. Dipeptidyl peptidase IV activity and \/ or structure homologues (DASH) and their substrates in cancer. Int J Biochem Cell Biol. 2004;36:408\u201321.","journal-title":"Int J Biochem Cell Biol"},{"key":"5646_CR2","first-page":"1","volume":"10","author":"F Liu","year":"2015","unstructured":"Liu F, Qi L, Liu B, Liu J, Zhang H, Che DH, et al. Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis. PLoS ONE. 2015;10:1\u201318.","journal-title":"PLoS ONE"},{"key":"5646_CR3","doi-asserted-by":"crossref","unstructured":"Yang L, Ma L, Lai D. Over-expression of fibroblast activation protein alpha increases tumor growth in xenografts of ovarian cancer cells. Acta Biochim Biophys Sin. 2013 928\u201337.","DOI":"10.1093\/abbs\/gmt095"},{"key":"5646_CR4","doi-asserted-by":"crossref","unstructured":"Busek P, Mateu R, Zubal M, Kotackova L, Sedo A. Targeting fibroblast activation protein in cancer\u2013prospects and caveats. Front Biosci. 2018 1933\u201368.","DOI":"10.2741\/4682"},{"key":"5646_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/rheumatology\/kex456","volume":"57","author":"T van der Geest","year":"2018","unstructured":"van der Geest T, Roeleveld DM, Walgreen B, Helsen MM, Nayak TK, Klein C, et al. Imaging fibroblast activation protein to monitor therapeutic effects of neutralizing interleukin-22 in collagen-induced arthritis. Rheumatol. 2018;57:737\u201347.","journal-title":"Rheumatol"},{"key":"5646_CR6","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1093\/eurheartj\/ehq519","volume":"32","author":"CE Brokopp","year":"2011","unstructured":"Brokopp CE, Schoenauer R, Richards P, Bauer S, Lohmann C, Emmert MY, et al. Fibroblast activation protein is induced by inflammation and degrades type i collagen in thin-cap fibroatheromata. Eur Heart J. 2011;32:2713\u201322.","journal-title":"Eur Heart J"},{"key":"5646_CR7","doi-asserted-by":"publisher","first-page":"8070","DOI":"10.1074\/jbc.M115.701433","volume":"291","author":"MH Fan","year":"2016","unstructured":"Fan MH, Zhu Q, Li HH, Ra HJ, Majumdar S, Gulick DL, et al. Fibroblast activation protein (FAP) accelerates collagen degradation and clearance from lungs in mice. J Biol Chem. 2016;291:8070\u201389.","journal-title":"J Biol Chem"},{"key":"5646_CR8","unstructured":"Lay AJ, Zhang HE, Mccaughan GW, Gorrell MD, Fap S, Fap C, et al. Fibroblast activation protein in liver fibrosis. Front Biosci. 2019 1\u201317."},{"key":"5646_CR9","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1073\/pnas.85.9.3110","volume":"85","author":"WJ Rettig","year":"1988","unstructured":"Rettig WJ, Garin-Chesa P, Beresford HR, Oettgen HF, Melamed MR, Old LJ. Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells. Proc Natl Acad Sci U S A. 1988;85:3110\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5646_CR10","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","volume":"59","author":"T Lindner","year":"2018","unstructured":"Lindner T, Loktev A, Altmann A, Giesel F, Kratochwil C, Debus J, et al. Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein. J Nucl Med. 2018;59:1415\u201322.","journal-title":"J Nucl Med"},{"key":"5646_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-04769-z","author":"H Chen","year":"2020","unstructured":"Chen H, Pang Y, Wu J, Zhao L, Hao B, Wu J, et al. Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging. 2020. https:\/\/doi.org\/10.1007\/s00259-020-04769-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5646_CR12","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","volume":"59","author":"A Loktev","year":"2018","unstructured":"Loktev A, Lindner T, Mier W, Debus J, Altmann A, J\u00e4ger D, et al. A tumor-imaging method targeting cancer-associated fibroblasts. J Nucl Med. 2018;59:1423\u20139.","journal-title":"J Nucl Med"},{"key":"5646_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05494-x","author":"J Kuten","year":"2021","unstructured":"Kuten J, Levine C, Shamni O, Pelles S, Wolf I, Lahat G, et al. Head-to-head comparison of [68Ga]Ga-FAPI-04 and [18F]FDG PET\/CT in evaluating the extent of disease in gastric adenocarcinoma. Eur J Nucl Med Mol Imaging. 2021. https:\/\/doi.org\/10.1007\/s00259-021-05494-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"5646_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s00259-020-04882-z","volume":"48","author":"X Shi","year":"2021","unstructured":"Shi X, Xing H, Yang X, Li F, Yao S, Zhang H, et al. Fibroblast imaging of hepatic carcinoma with 68Ga-FAPI-04 PET\/CT\u202f: a pilot study in patients with suspected hepatic nodules. Eur J Nucl Med Mol Imaging. 2021;48(1):196\u2013203.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5646_CR15","doi-asserted-by":"crossref","unstructured":"Kesch C, Yirga L, Dendl K, Handke A, Darr C, Krafft U, et al. High fibroblast\u2011activation\u2011protein expression in castration\u2011resistant prostate cancer supports the use of FAPI\u2011molecular theranostics. Eur J Nucl Med Mol Imaging. 2021 1\u20135.","DOI":"10.1007\/s00259-021-05423-y"},{"key":"5646_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.radonc.2020.06.040","volume":"150","author":"P Windisch","year":"2020","unstructured":"Windisch P, R\u00f6hrich M, Regnery S, Tonndorf-martini E, Held T, Lang K, et al. Fibroblast activation protein (FAP) specific PET for advanced target volume delineation in glioblastoma. Radiother Oncol. 2020;150:159\u201363.","journal-title":"Radiother Oncol"},{"key":"5646_CR17","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, et al. 68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer. J Nucl Med. 2019;60:801\u20135.","journal-title":"J Nucl Med"},{"key":"5646_CR18","doi-asserted-by":"publisher","first-page":"693640","DOI":"10.3389\/fonc.2021.693640","volume":"11","author":"H Wang","year":"2021","unstructured":"Wang H, Zhu W, Ren S, Kong Y, Huang Q, Zhao J. Ga-FAPI-04 versus 18F-FDG PET\/CT in the detection of hepatocellular carcinoma. Front Oncol. 2021;11:693640.","journal-title":"Front Oncol."},{"key":"5646_CR19","doi-asserted-by":"publisher","first-page":"8998","DOI":"10.1002\/anie.200800222","volume":"47","author":"PW Miller","year":"2008","unstructured":"Miller PW, Long NJ, Vilar R, Gee AD. Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography. Angew Chemie-Int Ed. 2008;47:8998\u20139033.","journal-title":"Angew Chemie-Int Ed"},{"key":"5646_CR20","doi-asserted-by":"publisher","unstructured":"Hu K, Li J, Wang L, Huang Y, Li L, Ye S, et al. Preclinical evaluation and pilot clinical study of [18F]AlF-labeled FAPI-tracer for PET imaging of cancer associated fibroblasts. Acta Pharm. Sin. B. 2021 In press. https:\/\/doi.org\/10.1016\/j.apsb.2021.09.032","DOI":"10.1016\/j.apsb.2021.09.032"},{"key":"5646_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05470-5","author":"S Wang","year":"2021","unstructured":"Wang S, Zhou X, Xu X, Ding J, Liu S, Hou X, et al. Clinical translational evaluation of Al18F-NOTA-FAPI for fibroblast activation protein-targeted tumour imaging. Eur J Nucl Med Mol Imaging. 2021. https:\/\/doi.org\/10.1007\/s00259-021-05470-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5646_CR22","first-page":"1","volume":"11","author":"X Jiang","year":"2021","unstructured":"Jiang X, Wang X, Shen T, Yao Y, Chen M, Li Z, et al. FAPI-04 PET\/CT Using [18F]AlF labeling strategy: automatic synthesis, quality control, and in vivo assessment in patient. Front Oncol. 2021;11:1\u20139.","journal-title":"Front Oncol"},{"key":"5646_CR23","doi-asserted-by":"publisher","first-page":"113502","DOI":"10.1016\/j.ejmech.2021.113502","volume":"221","author":"Y Huang","year":"2021","unstructured":"Huang Y, Li H, Ye S, Tang G, Liang Y, Hu K. Synthesis and preclinical evaluation of an Al18F radiofluorinated bivalent PSMA ligand. Eur J Med Chem. 2021;221:113502.","journal-title":"Eur J Med Chem."},{"key":"5646_CR24","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2967\/jnumed.118.224469","volume":"60","author":"A Loktev","year":"2019","unstructured":"Loktev A, Lindner T, Burger EM, Altmann A, Giesel F, Kratochwil C, et al. Development of fibroblast activation protein-targeted radiotracers with improved tumor retention. J Nucl Med. 2019;60:1421\u20139.","journal-title":"J Nucl Med"},{"key":"5646_CR25","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1007\/s00259-020-05091-4","volume":"48","author":"H Tan","year":"2021","unstructured":"Tan H, Sui X, Yin H, Yu H, Gu Y, Chen S, et al. Total-body PET\/CT using half-dose FDG and compared with conventional PET\/CT using full-dose FDG in lung cancer. Eur J Nucl Med Mol Imaging. 2021;48:1966\u201375.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5646_CR26","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2967\/jnumed.120.250597","volume":"62","author":"BA Spencer","year":"2021","unstructured":"Spencer BA, Berg E, Schmall JP, Omidvari N, Leung EK, Abdelhafez YG, et al. Performance evaluation of the uEXPLORER total-body PET\/CT scanner based on NEMA NU 2\u20132018 with additional tests to characterize PET scanners with a long axial field of view. J Nucl Med. 2021;62:861\u201370.","journal-title":"J Nucl Med"},{"key":"5646_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2967\/jnumed.120.244806","volume":"62","author":"A Altmann","year":"2021","unstructured":"Altmann A, Haberkorn U, Siveke J. The latest developments in imaging of fibroblast activation protein. J Nucl Med. 2021;62:160\u20137.","journal-title":"J Nucl Med"},{"key":"5646_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2967\/jnumed.120.245084","volume":"62","author":"FL Giesel","year":"2021","unstructured":"Giesel FL, Adeberg S, Syed M, Lindner T, Jim\u00e9nez-Franco LD, Mavriopoulou E, et al. FAPI-74 PET\/CT using either 18F-AlF or cold-kit 68Ga labeling: biodistribution, radiation dosimetry, and tumor delineation in lung cancer patients. J Nucl Med. 2021;62:201\u20137.","journal-title":"J Nucl Med"},{"key":"5646_CR29","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2967\/jnumed.119.236786","volume":"61","author":"C Meyer","year":"2020","unstructured":"Meyer C, Dahlbom M, Lindner T, Vauclin S, Mona C, Slavik R, et al. Radiation dosimetry and biodistribution of 68Ga-FAPI-46 PET imaging in cancer patients. J Nucl Med. 2020;61:1171\u20137.","journal-title":"J Nucl Med"},{"key":"5646_CR30","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.2967\/jnumed.120.242958","volume":"61","author":"J Toms","year":"2020","unstructured":"Toms J, Kogler J, Maschauer S, Daniel C, Schmidkonz C, Kuwert T, et al. Targeting fibroblast activation protein: radiosynthesis and preclinical evaluation of an 18F-labeled FAP inhibitor. J Nucl Med. 2020;61:1806\u201313.","journal-title":"J Nucl Med"},{"key":"5646_CR31","first-page":"1","volume":"11","author":"S Wang","year":"2021","unstructured":"Wang S, Zhou X, Xu X, Ding J, Liu T, Jiang J, et al. Dynamic PET\/CT imaging of 68Ga-FAPI-04 in chinese subjects. Front Oncol. 2021;11:1\u201311.","journal-title":"Front Oncol"},{"key":"5646_CR32","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2967\/jnumed.120.253062","volume":"62","author":"M Rohrich","year":"2021","unstructured":"Rohrich M, Naumann P, Giesel FL, Choyke PL, Staudinger F, Wefers A, et al. Impact of 68Ga-FAPI PET\/CT imaging on the therapeutic management of primary and recurrent pancreatic ductal adenocarcinomas. J Nucl Med. 2021;62:779\u201386.","journal-title":"J Nucl Med"},{"key":"5646_CR33","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1158\/1078-0432.CCR-07-0074","volume":"13","author":"DA Mankoff","year":"2007","unstructured":"Mankoff DA, Eary JF, Link JM, Muzi M, Rajendran JG, Spence AM, et al. Tumor-specific positron emission tomography imaging in patients: [18F]fluorodeoxyglucose and beyond. Clin Cancer Res. 2007;13:3460\u20139.","journal-title":"Clin Cancer Res"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-021-05646-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-021-05646-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-021-05646-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T01:03:49Z","timestamp":1655514229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-021-05646-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,11]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["5646"],"URL":"https:\/\/doi.org\/10.1007\/s00259-021-05646-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,11]]},"assertion":[{"value":"2 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants were carried out in accordance with the Ethics Committee of Nanfang Hospital (No. NFEC-2020\u2013205) and registered in the Chinese Clinical Trial Registry (ChiCTR2100045757).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}